Oral Administration of Silibinin Ameliorates Cognitive Deficits of Parkinson’s Disease Mouse Model by Restoring Mitochondrial Disorders in Hippocampus

2021 ◽  
Author(s):  
Xiumin Liu ◽  
Chenkang Wang ◽  
Weiwei Liu ◽  
Siaoyu Song ◽  
Jianing Fu ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Mouse Model ◽  
Oral Administration ◽  
Cognitive Deficits ◽  
Mitochondrial Disorders

Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease

2018 ◽  
Vol 9 (12) ◽  
pp. 6414-6426 ◽  
Author(s):  
Li-fan Zhang ◽  
Xiao-lin Yu ◽  
Mei Ji ◽  
Shu-ying Liu ◽  
Xiao-ling Wu ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Mouse Model ◽  
Cognitive Deficits ◽  
Neuroprotective Effects

Resveratrol exerts neuroprotective effects on the A53T α-synuclein mouse model of Parkinson's disease.

scholarly journals Cognitive deficits in a mouse model of pre-manifest Parkinson’s disease

2012 ◽  
Vol 35 (6) ◽  
pp. 870-882 ◽  
Author(s):  
Iddo Magen ◽  
Sheila M. Fleming ◽  
Chunni Zhu ◽  
Eddie C. Garcia ◽  
Katherine M. Cardiff ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Mouse Model ◽  
Cognitive Deficits

scholarly journals Impaired neurogenesis in the hippocampus of an adult VPS35 mutant mouse model of Parkinson's disease through interaction with APP

2021 ◽  
Vol 153 ◽  
pp. 105313
Author(s):  
Mei Jiang ◽  
Hai-Tao Tu ◽  
Ke Zhang ◽  
Wei Zhang ◽  
Wei-Ping Yu ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Parkinson's Disease ◽  
Mouse Model ◽  
Mutant Mouse ◽  
Impaired Neurogenesis

scholarly journals Therapeutic Potential of Magnetic Nanoparticle-Based Human Adipose-Derived Stem Cells in a Mouse Model of Parkinson’s Disease

2021 ◽  
Vol 22 (2) ◽  
pp. 654
Author(s):  
Ka Young Kim ◽  
Keun-A Chang
Keyword(s):  
Parkinson’S Disease ◽  
Stem Cells ◽  
Parkinson's Disease ◽  
Magnetic Nanoparticles ◽  
Substantia Nigra ◽  
Mouse Model ◽  
Magnetic Nanoparticle ◽  
Imaging System ◽  
Therapeutic Potential ◽  
Adipose Derived Stem Cells

Parkinson’s disease (PD) is a progressive neurodegenerative disease characterized by the loss of dopaminergic neurons in the substantia nigra. Several treatments for PD have focused on the management of physical symptoms using dopaminergic agents. However, these treatments induce various adverse effects, including hallucinations and cognitive impairment, owing to non-targeted brain delivery, while alleviating motor symptoms. Furthermore, these therapies are not considered ultimate cures owing to limited brain self-repair and regeneration abilities. In the present study, we aimed to investigate the therapeutic potential of human adipose-derived stem cells (hASCs) using magnetic nanoparticles in a 6-hydroxydopamine (6-OHDA)-induced PD mouse model. We used the Maestro imaging system and magnetic resonance imaging (MRI) for in vivo tracking after transplantation of magnetic nanoparticle-loaded hASCs to the PD mouse model. The Maestro imaging system revealed strong hASCs signals in the brains of PD model mice. In particular, MRI revealed hASCs distribution in the substantia nigra of hASCs-injected PD mice. Behavioral evaluations, including apomorphine-induced rotation and rotarod performance, were significantly recovered in hASCs-injected 6-OHDA induced PD mice when compared with saline-treated counterparts. Herein, we investigated whether hASCs transplantation using magnetic nanoparticles recovered motor functions through targeted brain distribution in a 6-OHDA induced PD mice. These results indicate that magnetic nanoparticle-based hASCs transplantation could be a potential therapeutic strategy in PD.

Sign in / Sign up

Export Citation Format

Share Document